Pondering over coffee tonight........




A Long List of Patents Owned by  ACIP  and Other CDC Members

The following is a partial list of some of the patents that are  owned or shared by members of the CDC and/or  ACIP  committee, including Dr. Paul  Offit:

  • "Nucleic acid vaccines for prevention of  flavivirus  infection"  -  This patent comes into play during the manufacturing process of vaccines  for yellow fever,  Zika, Dengue, West Nile virus and more.
  • Various vaccination testing methods  - When pharmaceutical companies need to test aspects of a new vaccine, they may utilize one of the CDC's patented testing methods including an artificial lung system  for  aerosol vaccines and  a process that screens new vaccines for human rhinoviruses.
  • Adjuvant patents  -  Adjuvants  are components within vaccinations intended to create an intensified immune reaction; members of the  ACIP  own patents on  adjuvants  used specifically in vaccinations created for premature babies and full term newborns.
  • Assays that assist  vaccine development  - During the vaccine development process, manufacturers will often observe biological samples for  specific antibodies; the CDC owns a patent on an assay  that facilitates this monitoring system.
  • Vaccine quality control  - patents on various aspects of quality control for vaccinations are utilized by pharmaceutical  companies on a large scale once a new vaccine is  actively distributed to the public.

In total, 56 individual patents were found to be owned or shared by one or more members of the  ACIP  committee or other committees within the CDC.

Members Claim They are Unbiased

When prompted with questions pertaining to  their financial connections with  pharmaceutical companies, most  ACIP  members claim they are able to remain unbiased despite the  rewards they receive every time a new vaccination is recommended to the public. In numerous instances,  vaccines  released to  the market  are  later removed  after  serious side effects are  documented. The rotavirus vaccine was one such example; it was pulled from the market in 1999, a year after its initial approval. In 2001, the  House Government Reform Committee found that four out of the eight  ACIP  members who voted to approve the vaccine had direct financial ties to one or more of the pharmaceutical companies who produced  the vaccine for public use. Similar situations involving many other vaccinations have been independently documented  over the course of nearly 20 years.

A Multi Billion Dollar Industry

The vaccination industry currently generates $30 billion in profit each year, some of which reaches the hands of the very people who create the vaccine schedule. Despite  concerns connecting vaccinations to the increase in  autism and a host of other disorders, the number of recommended vaccines continues to grow each year. With a new federal administration  interested in uncovering the dirty secrets hidden within alliances between CDC members and vaccine manufacturers, we may begin to see a wave of personal injury and wrongful death lawsuits related directly to unethical behaviors which have led to numerous unsafe vaccines being pushed on an unknowing public. If the  National Vaccine Injury Compensation Program  (NVICP) is amended or repealed, victims of vaccine damage will be legally permitted to file claims directly against vaccine manufacturers and  members of the  ACIP  committee who often have had knowledge of vaccine  risks yet continue to recommend their widespread use.


The CDC Immunization Safety Office is  responsible for investigating  the safety and effectiveness of all new vaccinations; once an investigation is considered complete, a recommendation is then made to the  CDC’s Advisory Committee on Immunization Practices (ACIP) who then  determines whether the new vaccine will be added to the current  vaccination schedule. Members of the  ACIP  committee include physicians such as Dr. Paul  Offit, who also serves as the  chief of infectious diseases at the Children's Hospital of Philadelphia.  Offit  and other  CDC members  own  numerous patents associated with vaccinations and regularly receive funding for their research work  from the very same  pharmaceutical companies who  manufacturer  vaccinations which are ultimately sold to the public. This situation creates an obvious conflict of interest, as  members of the  ACIP  committee  benefit financially every time a new vaccination is released to  the market.

Members of the  ACIP  Committee  Directly Influence Public Health

Each of the 12  members of the CDC's  ACIP  Committee has a significant influence on the health of nearly every member of the American population. Because they are responsible for adding to  and/or altering the national vaccine schedule, it is of critical importance that they remain objective and unbiased before determining whether a new vaccination is appropriate for use, particularly in the bodies of vulnerable young children. Unfortunately, a significant number of  ACIP  committee members  receive direct financial returns when more vaccinations are added to the current schedule. Many own  vaccination related patent(s) and/or stock shares of the pharmaceutical companies  responsible for supplying  new vaccines  to the public. Others receive research grant money, funding for their academic departments, or payments for the oversight of vaccine safety trials.